760 related articles for article (PubMed ID: 30817935)
1. Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?
Kaufman MJ; Kanayama G; Hudson JI; Pope HG
Neurosci Biobehav Rev; 2019 May; 100():180-207. PubMed ID: 30817935
[TBL] [Abstract][Full Text] [Related]
2. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.
Christou MA; Christou PA; Markozannes G; Tsatsoulis A; Mastorakos G; Tigas S
Sports Med; 2017 Sep; 47(9):1869-1883. PubMed ID: 28258581
[TBL] [Abstract][Full Text] [Related]
3. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
4. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
[TBL] [Abstract][Full Text] [Related]
5. Brain and cognition abnormalities in long-term anabolic-androgenic steroid users.
Kaufman MJ; Janes AC; Hudson JI; Brennan BP; Kanayama G; Kerrigan AR; Jensen JE; Pope HG
Drug Alcohol Depend; 2015 Jul; 152():47-56. PubMed ID: 25986964
[TBL] [Abstract][Full Text] [Related]
6. Anabolic androgenic steroid-induced hypogonadism, a reversible condition in male individuals? A systematic review.
Vilar Neto JO; da Silva CA; Bruno da Silva CA; Pinto DV; Caminha JSR; de Matos RS; Nunes Filho JCC; Alves FR; Magalhães SC; De Francesco Daher E
Andrologia; 2021 Aug; 53(7):e14062. PubMed ID: 33887077
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's associated amyloid and tau deposition co-localizes with a homeostatic myelin repair pathway in two mouse models of post-stroke mixed dementia.
Nguyen TV; Hayes M; Zbesko JC; Frye JB; Congrove NR; Belichenko NP; McKay BS; Longo FM; Doyle KP
Acta Neuropathol Commun; 2018 Sep; 6(1):100. PubMed ID: 30249297
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
10. Cypermethrin Stimulates GSK3β-Dependent Aβ and p-tau Proteins and Cognitive Loss in Young Rats: Reduced HB-EGF Signaling and Downstream Neuroinflammation as Critical Regulators.
Maurya SK; Mishra J; Abbas S; Bandyopadhyay S
Mol Neurobiol; 2016 Mar; 53(2):968-982. PubMed ID: 25575682
[TBL] [Abstract][Full Text] [Related]
11. The Central Effects of Androgenic-anabolic Steroid Use.
Mędraś M; Brona A; Jóźków P
J Addict Med; 2018; 12(3):184-192. PubMed ID: 29470183
[TBL] [Abstract][Full Text] [Related]
12. Key Peptides and Proteins in Alzheimer's Disease.
Penke B; Bogár F; Paragi G; Gera J; Fülöp L
Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
[TBL] [Abstract][Full Text] [Related]
13. Anabolic androgenic steroid dependence is associated with impaired emotion recognition.
Hauger LE; Sagoe D; Vaskinn A; Arnevik EA; Leknes S; Jørstad ML; Bjørnebekk A
Psychopharmacology (Berl); 2019 Sep; 236(9):2667-2676. PubMed ID: 30941469
[TBL] [Abstract][Full Text] [Related]
14. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem.
Kanayama G; Hudson JI; DeLuca J; Isaacs S; Baggish A; Weiner R; Bhasin S; Pope HG
Addiction; 2015 May; 110(5):823-31. PubMed ID: 25598171
[TBL] [Abstract][Full Text] [Related]
15. Stacking anabolic androgenic steroids (AAS) during puberty in rats: a neuroendocrine and behavioral assessment.
Wesson DW; McGinnis MY
Pharmacol Biochem Behav; 2006 Mar; 83(3):410-9. PubMed ID: 16603236
[TBL] [Abstract][Full Text] [Related]
16. Beyond the sleep-amyloid interactions in Alzheimer's disease pathogenesis.
Ning S; Jorfi M
J Neurophysiol; 2019 Jul; 122(1):1-4. PubMed ID: 30864847
[TBL] [Abstract][Full Text] [Related]
17. Role of insulin resistance in Alzheimer's disease.
Cai Z; Xiao M; Chang L; Yan LJ
Metab Brain Dis; 2015 Aug; 30(4):839-51. PubMed ID: 25399337
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use.
Baggish AL; Weiner RB; Kanayama G; Hudson JI; Lu MT; Hoffmann U; Pope HG
Circulation; 2017 May; 135(21):1991-2002. PubMed ID: 28533317
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
Chu J; Lauretti E; Craige CP; Praticò D
J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099
[TBL] [Abstract][Full Text] [Related]
20. Common symptoms associated with usage and cessation of anabolic androgenic steroids in men.
Sharma A; Grant B; Islam H; Kapoor A; Pradeep A; Jayasena CN
Best Pract Res Clin Endocrinol Metab; 2022 Sep; 36(5):101691. PubMed ID: 35999138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
